National Cancer Action Center

This week, the American Cancer Society Cancer Action Network submitted comments in a letter opposing several policies in the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters proposed rule for plan year 2027.

The American Cancer Society Cancer Action Network (ACS CAN) released today results from a survey exploring cancer patients and survivors’ attitudes toward vaccines.

Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 24 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow clinical trial sponsors to financially support patients to offset indirect or non-medical costs associated with clinical trial participation, such as travel, parking and lodging.

Washington, D.C. - Today, the Trump Administration released the list of 15 drugs for the next round of Medicare price negotiation, including four drugs to treat cancer: Erleada to treat prostate cancer, Kisqali to treat breast cancer, Verzenio to treat breast cancer, and Lenvima to treat thyroid cancer, endometrial cancer,